Transplantation 2021 Mar 10. Epub 2021 Mar 10.
Medical Affairs and Innovation, Héma-Québec, Québec, QC, Canada Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada Canadian Blood Services, Ottawa, ON, Canada Medical Affairs and Innovation, Héma-Québec, Saint-Laurent, QC, Canada Centre for Outcomes Research and Evaluation (CORE), Research Institute of McGill University Health Centre, Montréal, QC, Canada Division of Nephrology and the Multi Organ Transplant Program, Royal Victoria Hospital, McGill University Health Centre, Montréal, QC, Canada Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC, Canada Canadian Blood Services, Edmonton, AB, Canada Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada Population Health and Optimal Health Practices Research Unit, Trauma-Emergency-Critical Care Medicine, CHU de Québec, Université Laval Research Center, Québec, QC, Canada. Pediatrics Department, Intensive Care Division, Faculté de Médecine, Université Laval, Québec, QC, Canada. Transplant Québec, Montréal, QC, Canada. Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC, Canada.
The emergence of the SARS-CoV-2 virus responsible for the COVID-19 pandemic has raised concerns for programs overseeing donation and transplantation of cells, tissues and organs (CTO) that this virus might be transmissible by transfusion or transplantation. Transplant recipients are considered particularly vulnerable to pathogens due to immunosuppression, and SARS-CoV-2 is likely to generate complications if contracted. Several signs and symptoms observed in COVID-19 positive patients reflect damage to multiple organs and tissues, raising the possibility of extra-pulmonary SARS-CoV-2 infections and risk of transmission. Read More